Skin & aging Antioxidant dipeptide
Carnosine
Regulatory status
Status at a glance
503A compounding status
Not nominated
We found no pending nomination for the 503A bulks list. Unless the substance has another legal pathway (for example, a USP monograph or use in an FDA-approved drug), 503A pharmacies generally may not compound with it.
- FDA approval
- Not FDA-approved for any use
- 503B outsourcing
- Not determined
- Anti-doping (WADA)
- Not on the WADA Prohibited List
- DEA schedule
- Not a controlled substance
About peptide status
Most peptides discussed here are not FDA-approved for any use, and products labeled “research use only” are not for human use. Removal from Category 2 does not authorize compounding. PCAC votes are non-binding recommendations; FDA and HHS make the final decisions.
This is not medical or legal advice, and we do not publish dosing, sourcing or reconstitution information. Talk with a licensed clinician before using any peptide.
If you think you are having a medical emergency, call 911.
Key takeaway
Carnosine is a naturally occurring dipeptide, made of the amino acids beta-alanine and histidine, used in skincare as an antioxidant ingredient. Laboratory and ex-vivo skin studies suggest it can neutralize reactive oxygen species and limit glycation, a process in which sugars stiffen skin proteins, which is the rationale for using it in products aimed at the appearance of aging skin. As of 2026, the evidence for topical carnosine is largely from lab and ex-vivo studies rather than large human appearance trials.
At a glance
- What it is
- Cosmetic ingredient, a naturally occurring dipeptide used for its antioxidant properties
- FDA status
- Cosmetic ingredient rather than a drug, so does not require FDA approval
- Research
- Lab and ex-vivo studies point to antioxidant and anti-glycation activity; standalone human appearance trials are limited
- Main uses
- Products targeting the look of firmness, even tone, and protection from dullness
- Evidence strength
- Low research
Summary
Carnosine is a dipeptide used in skincare as an antioxidant ingredient. Learn how it works, what lab studies show, and why it is a cosmetic, not a drug.
What is carnosine?
Carnosine is a small peptide made of two amino acids, beta-alanine and histidine, that occurs naturally in the human body, especially in muscle and brain tissue. In skincare it is used as an antioxidant ingredient, often in products positioned for the appearance of aging or environmentally stressed skin. It is a cosmetic ingredient, not a drug, and is usually listed plainly as "carnosine" on ingredient labels.
How does it work?
Laboratory studies suggest carnosine acts mainly as an antioxidant and an anti-glycation agent. As an antioxidant, it can neutralize reactive oxygen species, the unstable molecules generated by UV light and pollution that are associated with the visible signs of skin aging. In an ex-vivo human skin study, topical carnosine reduced markers of UV-induced oxidative stress.
Its second proposed role is limiting glycation, a reaction in which sugar molecules bind to proteins such as collagen and form advanced glycation end-products that make those proteins stiff and dysfunctional. By slowing that reaction in laboratory models, carnosine is thought to help skin keep the appearance of suppleness. These are study findings; the benefit in finished cosmetics is described in appearance terms, such as supporting the look of firmness and a brighter, more even tone.
Is it FDA-approved?
Safety note
Status: Cosmetic ingredient rather than a drug, so does not require FDA approval
Category: Cosmetic and topical · Primary body area: Skin & aging
No, and it does not need to be. The FDA does not pre-approve cosmetic ingredients or products the way it approves drugs. A cosmetic may describe how it affects the look and feel of skin, but a claim that a product changes the structure or function of the body would make it a drug in the eyes of regulators. Carnosine is used within that cosmetic boundary, for the appearance of the skin.
What is it used for?
Carnosine is used in antioxidant and "anti-aging" skincare, typically serums and moisturizers. The appearance goals are protection against the dullness and uneven tone associated with oxidative stress, and support for the look of firm, smooth skin. It is often combined with other antioxidants.
What does the research show?
Editor’s note
Evidence strength: Low research
The case for topical carnosine rests on antioxidant and anti-glycation activity seen in laboratory and ex-vivo skin studies, with no sound standalone human trial showing an appearance benefit.
Most of the evidence is from laboratory and ex-vivo skin experiments rather than large human trials. According to PubMed, an ex-vivo human skin study found that topical carnosine lowered UV-induced reactive oxygen species and glycation markers. Independent, well-controlled trials of carnosine alone measuring wrinkle or firmness outcomes in people are lacking, and several studies that include carnosine test it inside multi-ingredient formulas, so its individual contribution is hard to isolate.
What are the side effects?
Carnosine is generally considered well tolerated on the skin, with a low potential for irritation at cosmetic use levels. As with any new skincare ingredient, people with sensitive or reactive skin may want to patch test first, since individual reactions vary.
Sources: an ex-vivo human skin study of topical carnosine and UV-induced oxidative stress (Girardi et al., Photochemistry and Photobiology, 2023, DOI: 10.1111/php.13850), indexed on PubMed; and cosmetic ingredient reference data on carnosine. This document is educational and does not constitute medical advice.
Registered human trials
0 registered human trials on ClinicalTrials.gov that we reviewed
Sources
- [1]
Compare every peptide’s status in the peptide regulatory status database
More for Skin & aging
View all skin & aging peptides →- Cosmetic & topical Skin & aging
Acetyl-Hexapeptide-8
Argireline
Acetyl hexapeptide-8, sold in skincare as Argireline, is a synthetic peptide modeled on the nerve protein SNAP-25 and marketed as a topical, "Botox-like" way to soften the appearance of expression lines. In lab and small clinical studies it interferes with the SNARE complex that nerves use to trigger muscle contraction, and a 2013 randomized study found it reduced the appearance of peri-orbital wrinkles over four weeks. It is a cosmetic ingredient rather than a drug, so it does not require FDA approval, and its evidence is rated Moderate.
- Cosmetic & topical Skin & aging
Acetyl-Octapeptide-3
SNAP-8
Acetyl octapeptide-3, sold in skincare as SNAP-8, is a synthetic eight-amino acid peptide modeled on the nerve protein SNAP-25 and marketed as a stronger successor to Argireline for softening the appearance of expression lines. Like Argireline, it is designed to interfere with the SNARE complex that nerves use to trigger muscle contraction, but its own published human evidence is thin and comes mostly from the manufacturer. It is a cosmetic ingredient rather than a drug, so it does not require FDA approval, and its evidence is rated Low.
- Cosmetic & topical Skin & aging
Acetyl-Tetrapeptide-5
Eyeseryl
Acetyl tetrapeptide-5, sold in skincare as Eyeseryl, is a synthetic four-amino acid peptide used in eye creams to soften the look of under-eye bags and puffiness. It is thought to work in two ways, by easing the fluid buildup that makes the under-eye area look swollen and by limiting the glycation that stiffens collagen, though its published evidence comes almost entirely from the manufacturer. It is a cosmetic ingredient rather than a drug, so it does not require FDA approval, and its evidence is rated Low.
- FDA-approved Skin & aging
Afamelanotide
Afamelanotide is a synthetic, longer-lasting analog of alpha-melanocyte-stimulating hormone (α-MSH) that activates the MC1R receptor on pigment cells to boost the skin's own protective eumelanin. The FDA approved it in 2019 as Scenesse, a subcutaneous implant for adults with erythropoietic protoporphyria (EPP), a rare light-sensitivity disorder. In the pivotal 2015 placebo-controlled trials, U.S. patients (94) logged a median 69.4 pain-free hours in direct sunlight versus 40.8 on placebo (P = 0.04). EU patients (74) logged 6.0 versus 0.8 hours (P = 0.005).
- FDA-approved Skin & aging
Bacitracin
Bacitracin is a cyclic polypeptide antibiotic produced by Bacillus bacteria that kills gram-positive bacteria by blocking the construction of their cell wall. It is best known as an over-the-counter topical ointment for preventing infection in minor cuts, scrapes, and burns, often combined with neomycin and polymyxin B in "triple antibiotic" products. It is widely available over the counter, but it is also a common cause of allergic skin reactions, and its injectable form was withdrawn over kidney-toxicity concerns.
- Cosmetic & topical Skin & aging
Copper-Tripeptide-1
GHK-Cu
Copper tripeptide-1, often called GHK-Cu, is a three-amino acid peptide (glycine-histidine-lysine) bound to a copper ion and used in skincare for its proposed role in skin renewal. Laboratory and animal studies show it can signal cells to make collagen and other matrix components. Independent human evidence is thin. In a randomized trial of 13 patients after CO2 laser resurfacing, GHK-Cu skincare showed no significant difference in redness or skin quality in blinded evaluations, though patients rated their overall skin quality higher (p = 0.04). As of 2026 it is a cosmetic ingredient, not an FDA-approved drug.